Concepedia
Statistics
Publications
4
Citations
466
H-Index
Active since
2011
Affiliations
Brigham and Women's Hospital(Current)
Harvard University
Dana-Farber/Harvard Cancer Center
Dana-Farber Cancer Institute
Rachel Ingraham is an author at Brigham and Women's Hospital specializing in medicine, cancer cell signaling, and oncology.
Publications per year
2011–2017
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi, Satoshi Kashiwagi, J. P. Yuan et al. · Cancer Research · 2011 · 250 citations · Full text
Medicine, Immunology, Oncology +17
mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors
Clare F. Malone, Chloe E. Emerson, Rachel Ingraham et al. · Cancer Discovery · 2017 · 109 citations · Full text
Medicine, Oncology, Pharmacology +17
Defining Key Signaling Nodes and Therapeutic Biomarkers in <i>NF1</i> -Mutant Cancers
Clare F. Malone, Jody Fromm Longo, Ophélia Maertens et al. · Cancer Discovery · 2014 · 64 citations
Medicine, Cancer Biology, Oncology +17
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
Rebecca Lock, Rachel Ingraham, Ophélia Maertens et al. · Journal of Clinical Investigation · 2016 · 43 citations · Full text
1–4 of 4